Peng Zhou

Peng Zhou has a diverse work experience spanning multiple industries. Peng started their career at Ochsner Health System as a Research Associate in 1997 and then moved on to Louisiana State University as a Research Associate from 2002 to 2005. Peng then worked as a Lab Manager at the Howard Hughes Medical Institute from 2005 to 2006. Peng then joined Merck as a Scientist in 2006, where they conducted various biomarker studies and contributed to the development of in vitro assays and animal models. Peng later worked at PPD as an Associate Research Scientist for a brief period in 2014. Peng then joined Integra LifeSciences as a Sr. Regulatory Affairs Specialist from 2014 to 2017, where they played a key role in regulatory submissions. Peng then joined Amicus Therapeutics as a Sr. Manager, Global Regulatory Affairs, where they worked from 2017 to 2022, handling complex regulatory submissions. Currently, Peng is working at Taiho Oncology, Inc. as an Associate Director, Regulatory Affairs Strategy starting from 2022.

Peng Zhou began their education journey in 1990, graduating from the University of Science and Technology of China in 1994 with a Bachelor of Science degree in Chemistry. They then pursued further education, obtaining a Master of Science degree in Biochemistry from Tulane University between 1994 and 1997. In 2014, Peng Zhou obtained a certification in Regulatory Affairs from the Regulatory Affairs Professionals Society (RAPS).